U.S. FDA approves Amicus Therapeutics' muscle disorder treatment

Amicus Therapeutics

28/09/2023 15:50

Sept 28 (Reuters) - Amicus Therapeutics  FOLD.O  on
Thursday said the U.S. Food and Drug Administration (FDA) had
approved its therapy to treat a muscle disorder called Pompe
disease.

 (Reporting by Sriparna Roy in Bengaluru; Editing by Shinjini
Ganguli)
 ((Sriparna.Roy@thomsonreuters.com;))